tweenvest

Sotac Pharmaceuticals Limited (NSEI: SOTAC)

Salud · Farmacéuticas · IN

129,35 Rs

-0,50 % hoy · +5,5 % 1 año

Ficha pública
Un resumen gratuito de Sotac Pharmaceuticals Limited, con datos del 15 nov 2026. El análisis completo está en la app.Abrir en la app

Sotac Pharmaceuticals Limited (NSEI: SOTAC) opera en la industria de farmacéuticas dentro del sector salud. Su valor en bolsa es de 15,20 M $ y tiene 127 empleados.

En los últimos doce meses la acción ha subido un 5,5 % y ha cotizado entre 86,00 y 139,65.

Tweenvest puntúa a Sotac Pharmaceuticals Limited en cuatro factores: calidad 61/100, valor 52/100, crecimiento 38/100, dividendo 39/100. Su punto más fuerte es calidad.

Evolución de la cotización de SOTAC

20 nov 2025 · 125,00Cierres semanales 87,40 – 138,5012 nov 2026 · 129,35

Cifras clave

Capitalización
15,20 M $
Ingresos (últ. 12 m)
14,34 M $
PER
24,79
BPA
7,82
Rent. por dividendo
0,15 %
Beta (5 años)
-0,18
Máximo 52 semanas
139,65 Rs
Mínimo 52 semanas
86,00 Rs
Volumen medio (3 m)
—
Acciones en circulación
11,05 M
Empleados
127
Próximos resultados
—

Sobre Sotac Pharmaceuticals Limited

Sotac Pharmaceuticals Ltd. is an India-based company operating within the pharmaceutical industry, specializing in the manufacturing of a diverse range of pharmaceutical formulations. The company functions primarily as a Contract Development and Manufacturing Organization (CDMO) and third-party manufacturer, serving both domestic and international clients. Its product portfolio includes various finished formulations such as tablets (general, beta-lactam, coated, and uncoated), capsules (general and beta-lactam), oral liquids, dry syrups, and external preparations like nasal sprays, relief sprays, and creams. Sotac Pharmaceuticals produces pharmaceuticals across numerous therapeutic areas, including anti-diabetic, anti-psychotic, vitamin and mineral supplements, anti-cold, anti-allergic, dermatological, antacid, anti-ulcerant, anti-emetic, cardiac, anti-hypertensive, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics (both IP-Lactams and Non-IP-Lactams), anti-fungal, and cephalosporin products. Beyond manufacturing, the company provides essential services to the pharmaceutical sector, including regulatory services, containment solutions, formulation development, clinical batch production, commercial scale production, and packaging. Sotac Pharmaceuticals exports globally, with the United States being a significant international market, and maintains a strong presence across India.

ISIN
INE0O2D01012
Fundada en
2014
Cotiza desde
13 abr 2023
Bolsa
National Stock Exchange of India
Divisa
INR
EmpresaCapitalizaciónPrecioDía
MFC Co., Ltd.KOSE: A43298015,44 M $2400,00 ₩+5,96 %
Curis Lifesciences LimitedNSEI: CURIS15,39 M $179,00 Rs+4,86 %
Tdspharm Co., Ltd.KOSDAQ: A46428015,23 M $3670,00 ₩-1,61 %
Bal Pharma LimitedBSE: 52482415,21 M $90,10 Rs+2,12 %
1CM Inc.CNSX: EPIC15,18 M $0,18 CA$0,00 %
Par Drugs and Chemicals LimitedNSEI: PAR15,03 M $114,11 Rs+0,66 %
Panchsheel Organics LimitedBSE: 53172614,90 M $106,64 Rs+0,32 %
Seoul Pharma Co., LtdKOSDAQ: A01868014,80 M $1695,00 ₩-1,57 %

Ver todas las empresas de farmacéuticas →